Candel Therapeutics, Inc. (CADL) - Margin dodolan resik

Tandha merek Candel Therapeutics Inc. (CADL)

Organic growth in clinical trials with scientific centers is driving the sales margin trend, where 0.00 indicates the value of this parameter. The foundation of Candel Therapeutics (CADL) is based on a closed viral therapy ecosystem with high barriers to entry. The company's innovative image relies on activating the patient's own immunity to fight tumors, as confirmed by the profit trend chart.

Margin resik Candel Therapeutics Inc. (CADL): kanggo periode 04.07.2022 - 19.11.2026

candeltx.com - rincian analitis lan metrik utama (CADL)

Ringkesan analitik perusahaan:Candel Therapeutics Inc. - CADL
Produk dadi Candel Therapeutics

The high scientific expertise of Candel Therapeutics (CADL) management in oncology is reflected in the trend of average sales margins, which demonstrates the efficiency of cost management for viral immunotherapy. This indicator is calculated as the ratio of net income to total revenue, allowing investors to assess the profit share of every dollar earned and determine the asset's financial stability without waiting for quarterly reports.

Analisis perusahaan pesaing

ONC: Margin dodolan resik|Margin resik Halozyme Inc. (HALO)|Margin resik RevMed|Rentabilitas dodolan resik AAPG (Ascentage Pharma Group)|Margin dodolan resik CGON|UroGen Pharma - Rentabilitas dodolan resik|Bicara Therapeutics - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Personalis Inc PSNL|Erasca Oncology - Margin dodolan resik|Tingkat bathi resik DCTH (Delcath Corp)|YMAB: Margin dodolan resik|AURA - Margin dodolan perusahaan|Margin resik Accuray Inc.|Margin resik SELLAS Life Sciences Group SLS|Margin dodolan resik ACTU|CTOR - Margin resik|Margin dodolan resik HURA (TuHURA Biosciences, Inc.)|Tingkat bathi resik TARA|FATE: Rentabilitas dodolan miturut bathi resik|WHWK (aadibio.com) - Rentabilitas dodolan resik|TCRX (TScan Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi resik|Margin resik Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Margin dodolan resik|CVM (CEL-SCI Corporation) - Rentabilitas resik perusahaan|Margin dodolan resik OSTX|Margin dodolan resik Radiopharm Theranostics Ltd (RADX)|Margin dodolan resik ARTV (Artiva Biotherapeutics)|Margin dodolan resik Adlai Nortye Ltd. ANL|Veru Inc - Margin dodolan resik|Margin dodolan perusahaan Tempest Therapeutics TPST|XLO: Margin dodolan resik|Enochian BioSciences (RENB) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MURA|Kairos Pharma Ltd - Margin bathi resik|Margin dodolan resik OKUR|CytoMed Therapeutics Limited (GDTC) - Tingkat bathi miturut bathi resik|Margin dodolan resik CRIS (Curis, Inc.)|APLM: Rentabilitas dodolan resik|Tharimmune Corporation - Margin dodolan resik|ADVB: Margin resik|GNPX: Margin dodolan resik|CLDI (Calidi Biotherapeutics Inc.) - Margin resik|Margin resik Sunshine Biopharma, Inc.|Margin dodolan resik xeneticbio.com|Margin resik Salarius (SLRX)|Rentabilitas dodolan miturut bathi resik Purple Biotech PPBT|Margin resik American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Margin resik|Checkpoint Therapeutics Inc. - Margin dodolan resik|Tingkat bathi resik ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Rentabilitas dodolan miturut bathi resik|Ikena Oncology, Inc. - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik NTBL|VIRX: Tingkat bathi resik|Margin resik MorphoSys Corporation (MOR)|NAYA - Margin resik|Margin dodolan resik AAPGV (Ascentage)